0G5I Stock Overview
Develops diagnostic systems used in point of care testing in Sweden. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Prolight Diagnostics AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.16 |
| 52 Week High | SEK 0.18 |
| 52 Week Low | SEK 0.16 |
| Beta | 2.38 |
| 1 Month Change | -12.78% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -97.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0G5I | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.3% | -2.2% |
| 1Y | n/a | -10.6% | 2.4% |
Return vs Industry: Insufficient data to determine how 0G5I performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0G5I performed against the UK Market.
Price Volatility
| 0G5I volatility | |
|---|---|
| 0G5I Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0G5I's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine 0G5I's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 16 | Ulf Bladin | prolightdiagnostics.se |
Prolight Diagnostics AB (publ) develops diagnostic systems used in point of care testing in Sweden. It engages in the development of PLD micro flex and flex membrane. Prolight Diagnostics AB (publ) was incorporated in 1999 and is based in Stockholm, Sweden.
Prolight Diagnostics AB (publ) Fundamentals Summary
| 0G5I fundamental statistics | |
|---|---|
| Market cap | SEK 92.68m |
| Earnings (TTM) | -SEK 139.04m |
| Revenue (TTM) | SEK 28.98m |
3.2x
P/S Ratio-0.7x
P/E RatioIs 0G5I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0G5I income statement (TTM) | |
|---|---|
| Revenue | SEK 28.98m |
| Cost of Revenue | SEK 0 |
| Gross Profit | SEK 28.98m |
| Other Expenses | SEK 168.02m |
| Earnings | -SEK 139.04m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 21, 2025
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 100.00% |
| Net Profit Margin | -479.73% |
| Debt/Equity Ratio | 0% |
How did 0G5I perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 16:00 |
| End of Day Share Price | 2024/11/28 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Prolight Diagnostics AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|